AASS (alpha-aminoadipic semialdehyde synthase; alias LKR/SDH) is a mitochondrial bifunctional enzyme that catalyzes the first two committed steps of the main (saccharopine) pathway of L-lysine degradation in the mitochondrial matrix. Its N-terminal domain carries lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) activity, which condenses L-lysine with 2-oxoglutarate to form L-saccharopine using NADPH; its C-terminal domain carries saccharopine dehydrogenase (SDH, EC 1.5.1.9) activity, which oxidizes L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic semialdehyde) and L-glutamate, reducing NAD+. The two domains are homologous to the yeast Lys1 and Lys9 enzymes, and the protein forms a homotetramer. AASS is expressed broadly with highest levels in liver and is induced by starvation. Loss of AASS activity causes autosomal recessive hyperlysinemia type 1 and saccharopinuria, metabolic conditions that are generally benign; AASS is also secondarily impaired in mitochondrial NADP(H) deficiency (DECRD, due to NADK2 mutation).
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
MARK AS OVER ANNOTATED |
Summary: Phylogenetic (IBA) placement in cytoplasm. AASS is a mitochondrial-matrix protein; "cytoplasm" is a correct but very broad ancestor localization that is superseded by the specific mitochondrial matrix annotation.
Reason: The precise, well-supported localization is the mitochondrial matrix (Reactome TAS, Ensembl IEA from mouse, UniProt SUBCELL; experimentally confirmed as mitochondrial by PMID:463877). The generic IBA "cytoplasm" call is uninformative relative to the matrix annotation and should not be treated as a core localization.
Propagation Review
Root cause:
NO FAILURE NON CORE
Failure modes:
GRANULARITY MISMATCH
Supporting Evidence:
PMID:463877
In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
|
|
GO:0019477
L-lysine catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: AASS catalyzes the first two steps of the saccharopine pathway of lysine degradation, the major route of L-lysine catabolism in humans. This is a core biological process for the gene and is independently supported by IMP evidence (PMID:10775527).
Reason: The phylogenetic assignment matches the experimentally established function: AASS converts L-lysine to alpha-aminoadipic semialdehyde, the committed entry into lysine catabolism.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
|
|
GO:0004753
saccharopine dehydrogenase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Grouping (parent) term for saccharopine dehydrogenase activity, assigned by phylogenetic inference. AASS possesses the specific NAD+, L-glutamate-forming SDH activity (GO:0047131); this broader term is a valid but less specific representation.
Reason: Correct at the family level. The C-terminal domain of AASS is the saccharopine dehydrogenase moiety, homologous to yeast Lys9. Retained as a valid grouping; the specific glutamate-forming activity (GO:0047131) captures the core function.
Supporting Evidence:
PMID:10775527
an apparently bifunctional protein, with the N-terminal half similar to that of yeast LYS1 and with the C-terminal half similar to that of yeast LYS9.
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic assignment to mitochondrion from UniProt Subcellular Location keyword mapping. Consistent with the experimentally verified mitochondrial localization and the N-terminal mitochondrial transit peptide.
Reason: AASS carries a mitochondrial transit peptide (residues 1-27) and is experimentally localized to mitochondria (PMID:463877); mitochondrion is correct, though the matrix annotation is more specific.
Supporting Evidence:
PMID:463877
saccharopine oxidoreductase was partially purified from human liver and characterized.
|
|
GO:0047130
saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assignment (ARBA/RHEA/EC mapping) of the lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) activity, the first catalytic step of AASS. This is a core molecular function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
Reason: Correct. This term (RHEA:19373, EC 1.5.1.8) is the NADPH-dependent condensation of L-lysine and 2-oxoglutarate to saccharopine catalyzed by the N-terminal LKR domain.
Supporting Evidence:
PMID:10775527
The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
file:human/AASS/AASS-uniprot.txt
Bifunctional enzyme that catalyzes the first two steps in
|
|
GO:0047131
saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assignment (ARBA/RHEA/EC mapping) of the saccharopine dehydrogenase (SDH, EC 1.5.1.9) activity, the second catalytic step of AASS. This is a core molecular function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
Reason: Correct. This term (RHEA:24520, EC 1.5.1.9) is the NAD+-dependent oxidation of saccharopine to alpha-aminoadipic semialdehyde and L-glutamate catalyzed by the C-terminal SDH domain.
Supporting Evidence:
PMID:10775527
The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
|
|
GO:0005759
mitochondrial matrix
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Automatic transfer (Ensembl Compara) from the mouse ortholog (Q99K67) placing AASS in the mitochondrial matrix, the compartment where the saccharopine pathway operates.
Reason: Mitochondrial matrix is the correct, specific compartment for this soluble matrix enzyme, consistent with the transit peptide and experimental mitochondrial localization (PMID:463877). This is the core localization.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-70938 |
ACCEPT |
Summary: Reactome (TAS) localization of the LKR reaction (lysine + alpha-ketoglutarate + NADPH => saccharopine) to the mitochondrial matrix. Consistent with the core localization.
Reason: The LKR step of AASS occurs in the mitochondrial matrix; Reactome curates this reaction there. Correct.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-70940 |
ACCEPT |
Summary: Reactome (TAS) localization of the SDH reaction (saccharopine + NAD+ => alpha-aminoadipic semialdehyde + glutamate) to the mitochondrial matrix. Consistent with the core localization.
Reason: The SDH step of AASS occurs in the mitochondrial matrix; Reactome curates this reaction there. Correct.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
|
|
GO:0005739
mitochondrion
|
EXP
PMID:463877 Familial hyperlysinemia: enzyme studies, diagnostic methods,... |
ACCEPT |
Summary: Experimental localization of AASS activities to mitochondria, from enzyme studies of the lysine-degrading activities partially purified from human liver.
Reason: Directly supported experimental annotation of mitochondrial localization; consistent with all other localization evidence.
Supporting Evidence:
PMID:463877
saccharopine oxidoreductase was partially purified from human liver and characterized.
|
|
GO:0047130
saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
|
EXP
PMID:463877 Familial hyperlysinemia: enzyme studies, diagnostic methods,... |
ACCEPT |
Summary: Experimental demonstration of lysine-ketoglutarate reductase (LKR) activity in human cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia. Core molecular function.
Reason: LKR activity was directly assayed and shown deficient in hyperlysinemia patients, establishing this NADP+/L-lysine-forming (EC 1.5.1.8) activity for the human enzyme.
Supporting Evidence:
PMID:463877
In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
|
|
GO:0047131
saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
|
EXP
PMID:463877 Familial hyperlysinemia: enzyme studies, diagnostic methods,... |
ACCEPT |
Summary: Experimental demonstration of saccharopine dehydrogenase (SDH) activity in human cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia. Core molecular function.
Reason: SDH activity was directly assayed and shown deficient in hyperlysinemia patients, establishing this NAD+/L-glutamate-forming (EC 1.5.1.9) activity for the human enzyme.
Supporting Evidence:
PMID:463877
In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: High-throughput identification of AASS in the high-confidence human mitochondrial proteome (MitoCoP). Corroborates the mitochondrial localization.
Reason: Consistent proteome-scale evidence supporting mitochondrial localization, in agreement with the experimental and computational annotations.
Supporting Evidence:
PMID:34800366
mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
|
|
GO:0047130
saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
|
IMP
PMID:10775527 Identification of the alpha-aminoadipic semialdehyde synthas... |
ACCEPT |
Summary: Loss-of-function evidence: a homozygous frameshift/premature-stop AASS variant in a hyperlysinemia patient abolishes the enzyme, supporting the LKR (EC 1.5.1.8) activity of AASS. Core molecular function.
Reason: Mutational (IMP) evidence links AASS specifically to the LKR activity of the lysine-degradation pathway.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
|
|
GO:0019477
L-lysine catabolic process
|
IMP
PMID:10775527 Identification of the alpha-aminoadipic semialdehyde synthas... |
ACCEPT |
Summary: Mutational evidence that AASS is required for L-lysine catabolism: inactivating AASS variants cause hyperlysinemia (accumulation of lysine). Core biological process.
Reason: Directly establishes AASS involvement in the L-lysine catabolic process via a loss-of-function patient allele.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
|
|
GO:0047131
saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
|
IMP
PMID:10775527 Identification of the alpha-aminoadipic semialdehyde synthas... |
ACCEPT |
Summary: Loss-of-function evidence: an inactivating AASS variant in a hyperlysinemia patient supports the SDH (EC 1.5.1.9) activity of AASS. Core molecular function.
Reason: Mutational (IMP) evidence links AASS to the saccharopine dehydrogenase activity of the lysine-degradation pathway; both AASS activities are lost in the patient.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
|
|
GO:0000122
negative regulation of transcription by RNA polymerase II
|
ISS
GO_REF:0000024 |
MARK AS OVER ANNOTATED |
Summary: ISS transfer from the Drosophila ortholog dLKR/SDH (UniProtKB:Q9VLX0), which was reported to have a nuclear/transcriptional moonlighting role in fly. No experimental support in human, and the assignment conflicts with the established mitochondrial-matrix metabolic localization of the human enzyme.
Reason: This is a species-specific moonlighting function reported for the Drosophila protein, transferred by sequence similarity from a single non-mammalian ortholog. Human AASS is a mitochondrial-matrix enzyme with no evidence for transcriptional regulation; the transferred nuclear role is not validated for human and is not a core function. Per curation policy this ISS transfer is marked as over-annotated rather than removed.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q9VLX0
· Drosophila melanogaster LKR/SDH (dLKR/SDH)
SUPPORTS SOURCE BUT NOT TARGET
Nuclear/transcriptional moonlighting reported for the fly enzyme; not conserved or validated for human AASS.
|
|
GO:0003714
transcription corepressor activity
|
ISS
GO_REF:0000024 |
MARK AS OVER ANNOTATED |
Summary: ISS transfer from the Drosophila ortholog (UniProtKB:Q9VLX0) of a transcription corepressor moonlighting activity. Not supported for human AASS and inconsistent with its mitochondrial-matrix localization; also a "binding/regulatory" MF that is not the gene's core catalytic function.
Reason: The corepressor role was described for the fly enzyme and transferred by similarity; there is no human experimental evidence, and a mitochondrial-matrix oxidoreductase is not expected to act as a nuclear transcription corepressor. Marked over-annotated.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q9VLX0
· Drosophila melanogaster LKR/SDH (dLKR/SDH)
SUPPORTS SOURCE BUT NOT TARGET
Corepressor moonlighting activity reported for the fly enzyme; not validated for human AASS.
|
|
GO:0004754
saccharopine dehydrogenase (NAD+, L-lysine-forming) activity
|
ISS
GO_REF:0000024 |
MODIFY |
Summary: ISS transfer (from Drosophila Q9VLX0) of the L-lysine-forming (biosynthetic, yeast Lys1-type) direction of saccharopine dehydrogenase. This is the reverse (anabolic) reaction; the human enzyme runs the catabolic activities (LKR GO:0047130 and glutamate-forming SDH GO:0047131), not lysine biosynthesis.
Reason: Mammals do not synthesize lysine via saccharopine; AASS is catabolic. The correct catalytic activities are the NADP+, L-lysine-forming reductase (GO:0047130) and the NAD+, L-glutamate-forming dehydrogenase (GO:0047131). The lysine-forming SDH direction (GO:0004754) is the wrong physiological direction for the human enzyme.
Proposed replacements:
saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
Supporting Evidence:
file:human/AASS/AASS-uniprot.txt
the lysine ketoglutarate reductase and saccharopine dehydrogenase
|
|
GO:0005829
cytosol
|
ISS
GO_REF:0000024 |
MARK AS OVER ANNOTATED |
Summary: ISS transfer of cytosolic localization from the Drosophila ortholog (UniProtKB:Q9VLX0), likely associated with the reported fly moonlighting role. Contradicts the mitochondrial-matrix localization of human AASS.
Reason: Human AASS has an N-terminal mitochondrial transit peptide and is experimentally localized to the mitochondrial matrix; a cytosolic localization transferred from a fly ortholog is not supported and conflicts with the core compartment. Marked over-annotated.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
COMPARTMENT OR COMPLEX MISMATCH
Sources checked:
UniProtKB:Q9VLX0
· Drosophila melanogaster LKR/SDH (dLKR/SDH)
SUPPORTS SOURCE BUT NOT TARGET
Human AASS has a mitochondrial transit peptide and matrix localization; cytosolic transfer is unsafe.
|
|
GO:0005634
nucleus
|
ISS
GO_REF:0000024 |
MARK AS OVER ANNOTATED |
Summary: ISS transfer of nuclear localization from the Drosophila ortholog (UniProtKB:Q9VLX0), linked to the fly transcriptional moonlighting role. No human evidence; conflicts with the established mitochondrial-matrix localization.
Reason: Nuclear localization is part of the Drosophila-specific moonlighting function and is not validated for the human mitochondrial-matrix enzyme. Marked over-annotated.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
COMPARTMENT OR COMPLEX MISMATCH
Sources checked:
UniProtKB:Q9VLX0
· Drosophila melanogaster LKR/SDH (dLKR/SDH)
SUPPORTS SOURCE BUT NOT TARGET
Nuclear localization is part of the fly moonlighting role; not validated for the human mitochondrial-matrix enzyme.
|
|
GO:0042393
histone binding
|
ISS
GO_REF:0000024 |
MARK AS OVER ANNOTATED |
Summary: ISS transfer of histone binding from the Drosophila ortholog (UniProtKB:Q9VLX0), associated with the reported fly chromatin/transcription moonlighting role. Not supported for human AASS.
Reason: Histone binding was inferred from the fly moonlighting function and transferred by similarity; there is no human experimental support, and it is inconsistent with the mitochondrial-matrix metabolic role. Marked over-annotated.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q9VLX0
· Drosophila melanogaster LKR/SDH (dLKR/SDH)
SUPPORTS SOURCE BUT NOT TARGET
Histone binding tied to the fly chromatin moonlighting role; not validated for human AASS.
|
|
GO:0005739
mitochondrion
|
TAS
PMID:10567240 Lysine degradation through the saccharopine pathway in mamma... |
ACCEPT |
Summary: Author statement (TAS) that the bifunctional LKR/SDH enzyme is a mitochondrial protein, based on sequence analysis of the mammalian (mouse) enzyme. Consistent with the human mitochondrial localization.
Reason: Corroborates mitochondrial localization; the paper characterizes the mammalian bifunctional LKR/SDH and infers a mitochondrial targeting sequence.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
|
Q: Does human AASS have any validated moonlighting function outside the mitochondrion (e.g. a nuclear/transcriptional role analogous to that reported for the Drosophila ortholog), or is such a role restricted to insects?
Experiment: Test whether endogenous AASS is detectable in the nucleus of human cells and whether it associates with chromatin or represses transcription, to determine if the Drosophila-derived transcriptional moonlighting annotations are conserved in humans.
UniProt: Q9UDR5 (AASS_HUMAN); HGNC:17366; gene ID 10157; chromosome 7q31.3.
926 aa precursor; mitochondrial transit peptide (1..27); mature chain 28..926.
AASS = alpha-aminoadipic semialdehyde synthase, mitochondrial. It is a bifunctional
enzyme (alias LKR/SDH) that catalyzes the first two steps of the main (saccharopine)
pathway of L-lysine degradation in the mitochondrial matrix:
NADPH + H(+)"; PhysiologicalDirection=right-to-left (i.e. lysine-forming direction
is left, so physiological flux is lysine + 2-OG → saccharopine). RHEA:19373; EC 1.5.1.8.
GO term: GO:0047130 saccharopine dehydrogenase (NADP+, L-lysine-forming) activity.
Saccharopine dehydrogenase (SDH, EC 1.5.1.9) — C-terminal domain
(region 477..926). Oxidizes L-saccharopine to (S)-2-amino-6-oxohexanoate
(= L-2-aminoadipate-6-semialdehyde / alpha-aminoadipic semialdehyde) + L-glutamate,
reducing NAD+. UniProt: "L-saccharopine + NAD(+) + H2O = (S)-2-amino-6-oxohexanoate +
L-glutamate + NADH + H(+)"; PhysiologicalDirection=left-to-right. RHEA:24520; EC 1.5.1.9.
GO term: GO:0047131 saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity.
Net: L-lysine + 2-OG + NADPH → saccharopine → alpha-aminoadipate-6-semialdehyde +
L-glutamate. This is the committed entry into lysine catabolism (steps 1/6 and 2/6 of
glutaryl-CoA from L-lysine; UniPathway UPA00868 UER00835/UER00836).
Structure: homotetramer (by similarity to mouse Q99K67). NAD-binding residues in SDH
domain resolved by crystallography (PDB 5L76/5L78/5O1N/5O1O/5O1P for SDH domain 455-926;
8DDA/8E8T/8E8U/8E8V for LKR domain). L-saccharopine-binding residues 577-578, 604, 703,
724-726 (by similarity to Q9P4R4).
Tissue: expressed broadly, highest in liver. Induced by starvation (by similarity).
id: Q9UDR5
gene_symbol: AASS
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
AASS (alpha-aminoadipic semialdehyde synthase; alias LKR/SDH) is a mitochondrial
bifunctional enzyme that catalyzes the first two committed steps of the main
(saccharopine) pathway of L-lysine degradation in the mitochondrial matrix. Its
N-terminal domain carries lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) activity,
which condenses L-lysine with 2-oxoglutarate to form L-saccharopine using NADPH; its
C-terminal domain carries saccharopine dehydrogenase (SDH, EC 1.5.1.9) activity, which
oxidizes L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic
semialdehyde) and L-glutamate, reducing NAD+. The two domains are homologous to the
yeast Lys1 and Lys9 enzymes, and the protein forms a homotetramer. AASS is expressed
broadly with highest levels in liver and is induced by starvation. Loss of AASS activity
causes autosomal recessive hyperlysinemia type 1 and saccharopinuria, metabolic
conditions that are generally benign; AASS is also secondarily impaired in
mitochondrial NADP(H) deficiency (DECRD, due to NADK2 mutation).
existing_annotations:
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetic (IBA) placement in cytoplasm. AASS is a mitochondrial-matrix protein;
"cytoplasm" is a correct but very broad ancestor localization that is superseded by
the specific mitochondrial matrix annotation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The precise, well-supported localization is the mitochondrial matrix (Reactome TAS,
Ensembl IEA from mouse, UniProt SUBCELL; experimentally confirmed as mitochondrial by
PMID:463877). The generic IBA "cytoplasm" call is uninformative relative to the matrix
annotation and should not be treated as a core localization.
propagation_review:
root_cause: NO_FAILURE_NON_CORE
failure_modes:
- GRANULARITY_MISMATCH
supported_by:
- reference_id: PMID:463877
supporting_text: >-
In all instances there was a deficiency in lysine-ketoglutarate reductase,
saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- term:
id: GO:0019477
label: L-lysine catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
AASS catalyzes the first two steps of the saccharopine pathway of lysine degradation,
the major route of L-lysine catabolism in humans. This is a core biological process
for the gene and is independently supported by IMP evidence (PMID:10775527).
action: ACCEPT
reason: >-
The phylogenetic assignment matches the experimentally established function: AASS
converts L-lysine to alpha-aminoadipic semialdehyde, the committed entry into lysine
catabolism.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
we propose that AASS catalyzes the first two steps of the major lysine-degradation
pathway in human cells and that inactivating mutations in the AASS gene are a cause
of hyperlysinemia.
- term:
id: GO:0004753
label: saccharopine dehydrogenase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Grouping (parent) term for saccharopine dehydrogenase activity, assigned by
phylogenetic inference. AASS possesses the specific NAD+, L-glutamate-forming SDH
activity (GO:0047131); this broader term is a valid but less specific representation.
action: ACCEPT
reason: >-
Correct at the family level. The C-terminal domain of AASS is the saccharopine
dehydrogenase moiety, homologous to yeast Lys9. Retained as a valid grouping;
the specific glutamate-forming activity (GO:0047131) captures the core function.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
an apparently bifunctional protein, with the N-terminal half similar to that of
yeast LYS1 and with the C-terminal half similar to that of yeast LYS9.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic assignment to mitochondrion from UniProt Subcellular Location keyword
mapping. Consistent with the experimentally verified mitochondrial localization and
the N-terminal mitochondrial transit peptide.
action: ACCEPT
reason: >-
AASS carries a mitochondrial transit peptide (residues 1-27) and is experimentally
localized to mitochondria (PMID:463877); mitochondrion is correct, though the matrix
annotation is more specific.
supported_by:
- reference_id: PMID:463877
supporting_text: >-
saccharopine oxidoreductase was partially purified from human liver and
characterized.
- term:
id: GO:0047130
label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic assignment (ARBA/RHEA/EC mapping) of the lysine-ketoglutarate reductase
(LKR, EC 1.5.1.8) activity, the first catalytic step of AASS. This is a core molecular
function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
action: ACCEPT
reason: >-
Correct. This term (RHEA:19373, EC 1.5.1.8) is the NADPH-dependent condensation of
L-lysine and 2-oxoglutarate to saccharopine catalyzed by the N-terminal LKR domain.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
The first two steps in the mammalian lysine-degradation pathway are catalyzed by
lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
- reference_id: file:human/AASS/AASS-uniprot.txt
supporting_text: >-
Bifunctional enzyme that catalyzes the first two steps in
- term:
id: GO:0047131
label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic assignment (ARBA/RHEA/EC mapping) of the saccharopine dehydrogenase (SDH,
EC 1.5.1.9) activity, the second catalytic step of AASS. This is a core molecular
function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
action: ACCEPT
reason: >-
Correct. This term (RHEA:24520, EC 1.5.1.9) is the NAD+-dependent oxidation of
saccharopine to alpha-aminoadipic semialdehyde and L-glutamate catalyzed by the
C-terminal SDH domain.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
The first two steps in the mammalian lysine-degradation pathway are catalyzed by
lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: is_active_in
review:
summary: >-
Automatic transfer (Ensembl Compara) from the mouse ortholog (Q99K67) placing AASS in
the mitochondrial matrix, the compartment where the saccharopine pathway operates.
action: ACCEPT
reason: >-
Mitochondrial matrix is the correct, specific compartment for this soluble matrix
enzyme, consistent with the transit peptide and experimental mitochondrial
localization (PMID:463877). This is the core localization.
supported_by:
- reference_id: PMID:10567240
supporting_text: >-
the bifunctional enzyme is likely to be a mitochondrial protein.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70938
qualifier: located_in
review:
summary: >-
Reactome (TAS) localization of the LKR reaction (lysine + alpha-ketoglutarate + NADPH
=> saccharopine) to the mitochondrial matrix. Consistent with the core localization.
action: ACCEPT
reason: >-
The LKR step of AASS occurs in the mitochondrial matrix; Reactome curates this
reaction there. Correct.
supported_by:
- reference_id: PMID:10567240
supporting_text: >-
the bifunctional enzyme is likely to be a mitochondrial protein.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70940
qualifier: located_in
review:
summary: >-
Reactome (TAS) localization of the SDH reaction (saccharopine + NAD+ => alpha-aminoadipic
semialdehyde + glutamate) to the mitochondrial matrix. Consistent with the core
localization.
action: ACCEPT
reason: >-
The SDH step of AASS occurs in the mitochondrial matrix; Reactome curates this
reaction there. Correct.
supported_by:
- reference_id: PMID:10567240
supporting_text: >-
the bifunctional enzyme is likely to be a mitochondrial protein.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: EXP
original_reference_id: PMID:463877
qualifier: located_in
review:
summary: >-
Experimental localization of AASS activities to mitochondria, from enzyme studies of
the lysine-degrading activities partially purified from human liver.
action: ACCEPT
reason: >-
Directly supported experimental annotation of mitochondrial localization; consistent
with all other localization evidence.
supported_by:
- reference_id: PMID:463877
supporting_text: >-
saccharopine oxidoreductase was partially purified from human liver and
characterized.
- term:
id: GO:0047130
label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
evidence_type: EXP
original_reference_id: PMID:463877
qualifier: enables
review:
summary: >-
Experimental demonstration of lysine-ketoglutarate reductase (LKR) activity in human
cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia.
Core molecular function.
action: ACCEPT
reason: >-
LKR activity was directly assayed and shown deficient in hyperlysinemia patients,
establishing this NADP+/L-lysine-forming (EC 1.5.1.8) activity for the human enzyme.
supported_by:
- reference_id: PMID:463877
supporting_text: >-
In all instances there was a deficiency in lysine-ketoglutarate reductase,
saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- term:
id: GO:0047131
label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
evidence_type: EXP
original_reference_id: PMID:463877
qualifier: enables
review:
summary: >-
Experimental demonstration of saccharopine dehydrogenase (SDH) activity in human
cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia.
Core molecular function.
action: ACCEPT
reason: >-
SDH activity was directly assayed and shown deficient in hyperlysinemia patients,
establishing this NAD+/L-glutamate-forming (EC 1.5.1.9) activity for the human enzyme.
supported_by:
- reference_id: PMID:463877
supporting_text: >-
In all instances there was a deficiency in lysine-ketoglutarate reductase,
saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
High-throughput identification of AASS in the high-confidence human mitochondrial
proteome (MitoCoP). Corroborates the mitochondrial localization.
action: ACCEPT
reason: >-
Consistent proteome-scale evidence supporting mitochondrial localization, in agreement
with the experimental and computational annotations.
supported_by:
- reference_id: PMID:34800366
supporting_text: >-
mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
- term:
id: GO:0047130
label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
evidence_type: IMP
original_reference_id: PMID:10775527
qualifier: enables
review:
summary: >-
Loss-of-function evidence: a homozygous frameshift/premature-stop AASS variant in a
hyperlysinemia patient abolishes the enzyme, supporting the LKR (EC 1.5.1.8) activity
of AASS. Core molecular function.
action: ACCEPT
reason: >-
Mutational (IMP) evidence links AASS specifically to the LKR activity of the
lysine-degradation pathway.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
we propose that AASS catalyzes the first two steps of the major lysine-degradation
pathway in human cells and that inactivating mutations in the AASS gene are a cause
of hyperlysinemia.
- term:
id: GO:0019477
label: L-lysine catabolic process
evidence_type: IMP
original_reference_id: PMID:10775527
qualifier: involved_in
review:
summary: >-
Mutational evidence that AASS is required for L-lysine catabolism: inactivating AASS
variants cause hyperlysinemia (accumulation of lysine). Core biological process.
action: ACCEPT
reason: >-
Directly establishes AASS involvement in the L-lysine catabolic process via a
loss-of-function patient allele.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
we propose that AASS catalyzes the first two steps of the major lysine-degradation
pathway in human cells and that inactivating mutations in the AASS gene are a cause
of hyperlysinemia.
- term:
id: GO:0047131
label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
evidence_type: IMP
original_reference_id: PMID:10775527
qualifier: enables
review:
summary: >-
Loss-of-function evidence: an inactivating AASS variant in a hyperlysinemia patient
supports the SDH (EC 1.5.1.9) activity of AASS. Core molecular function.
action: ACCEPT
reason: >-
Mutational (IMP) evidence links AASS to the saccharopine dehydrogenase activity of the
lysine-degradation pathway; both AASS activities are lost in the patient.
supported_by:
- reference_id: PMID:10775527
supporting_text: >-
we propose that AASS catalyzes the first two steps of the major lysine-degradation
pathway in human cells and that inactivating mutations in the AASS gene are a cause
of hyperlysinemia.
- term:
id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
ISS transfer from the Drosophila ortholog dLKR/SDH (UniProtKB:Q9VLX0), which was
reported to have a nuclear/transcriptional moonlighting role in fly. No experimental
support in human, and the assignment conflicts with the established mitochondrial-matrix
metabolic localization of the human enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is a species-specific moonlighting function reported for the Drosophila protein,
transferred by sequence similarity from a single non-mammalian ortholog. Human AASS
is a mitochondrial-matrix enzyme with no evidence for transcriptional regulation; the
transferred nuclear role is not validated for human and is not a core function.
Per curation policy this ISS transfer is marked as over-annotated rather than removed.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- FUNCTIONAL_DIVERGENCE
source_entities:
- source_id: UniProtKB:Q9VLX0
source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Nuclear/transcriptional moonlighting reported for the fly enzyme; not conserved
or validated for human AASS.
- term:
id: GO:0003714
label: transcription corepressor activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
ISS transfer from the Drosophila ortholog (UniProtKB:Q9VLX0) of a transcription
corepressor moonlighting activity. Not supported for human AASS and inconsistent with
its mitochondrial-matrix localization; also a "binding/regulatory" MF that is not the
gene's core catalytic function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The corepressor role was described for the fly enzyme and transferred by similarity;
there is no human experimental evidence, and a mitochondrial-matrix oxidoreductase is
not expected to act as a nuclear transcription corepressor. Marked over-annotated.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- FUNCTIONAL_DIVERGENCE
source_entities:
- source_id: UniProtKB:Q9VLX0
source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Corepressor moonlighting activity reported for the fly enzyme; not validated for
human AASS.
- term:
id: GO:0004754
label: saccharopine dehydrogenase (NAD+, L-lysine-forming) activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
ISS transfer (from Drosophila Q9VLX0) of the L-lysine-forming (biosynthetic, yeast
Lys1-type) direction of saccharopine dehydrogenase. This is the reverse (anabolic)
reaction; the human enzyme runs the catabolic activities (LKR GO:0047130 and
glutamate-forming SDH GO:0047131), not lysine biosynthesis.
action: MODIFY
reason: >-
Mammals do not synthesize lysine via saccharopine; AASS is catabolic. The correct
catalytic activities are the NADP+, L-lysine-forming reductase (GO:0047130) and the
NAD+, L-glutamate-forming dehydrogenase (GO:0047131). The lysine-forming SDH direction
(GO:0004754) is the wrong physiological direction for the human enzyme.
proposed_replacement_terms:
- id: GO:0047131
label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
supported_by:
- reference_id: file:human/AASS/AASS-uniprot.txt
supporting_text: >-
the lysine ketoglutarate reductase and saccharopine dehydrogenase
- term:
id: GO:0005829
label: cytosol
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
ISS transfer of cytosolic localization from the Drosophila ortholog (UniProtKB:Q9VLX0),
likely associated with the reported fly moonlighting role. Contradicts the
mitochondrial-matrix localization of human AASS.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Human AASS has an N-terminal mitochondrial transit peptide and is experimentally
localized to the mitochondrial matrix; a cytosolic localization transferred from a fly
ortholog is not supported and conflicts with the core compartment. Marked over-annotated.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- COMPARTMENT_OR_COMPLEX_MISMATCH
source_entities:
- source_id: UniProtKB:Q9VLX0
source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Human AASS has a mitochondrial transit peptide and matrix localization; cytosolic
transfer is unsafe.
- term:
id: GO:0005634
label: nucleus
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
ISS transfer of nuclear localization from the Drosophila ortholog (UniProtKB:Q9VLX0),
linked to the fly transcriptional moonlighting role. No human evidence; conflicts with
the established mitochondrial-matrix localization.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Nuclear localization is part of the Drosophila-specific moonlighting function and is
not validated for the human mitochondrial-matrix enzyme. Marked over-annotated.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- COMPARTMENT_OR_COMPLEX_MISMATCH
source_entities:
- source_id: UniProtKB:Q9VLX0
source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Nuclear localization is part of the fly moonlighting role; not validated for the
human mitochondrial-matrix enzyme.
- term:
id: GO:0042393
label: histone binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
ISS transfer of histone binding from the Drosophila ortholog (UniProtKB:Q9VLX0),
associated with the reported fly chromatin/transcription moonlighting role. Not
supported for human AASS.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Histone binding was inferred from the fly moonlighting function and transferred by
similarity; there is no human experimental support, and it is inconsistent with the
mitochondrial-matrix metabolic role. Marked over-annotated.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- FUNCTIONAL_DIVERGENCE
source_entities:
- source_id: UniProtKB:Q9VLX0
source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: >-
Histone binding tied to the fly chromatin moonlighting role; not validated for
human AASS.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: TAS
original_reference_id: PMID:10567240
qualifier: located_in
review:
summary: >-
Author statement (TAS) that the bifunctional LKR/SDH enzyme is a mitochondrial protein,
based on sequence analysis of the mammalian (mouse) enzyme. Consistent with the human
mitochondrial localization.
action: ACCEPT
reason: >-
Corroborates mitochondrial localization; the paper characterizes the mammalian
bifunctional LKR/SDH and infers a mitochondrial targeting sequence.
supported_by:
- reference_id: PMID:10567240
supporting_text: >-
the bifunctional enzyme is likely to be a mitochondrial protein.
core_functions:
- description: >-
Lysine-ketoglutarate reductase (LKR) activity: the N-terminal domain condenses
L-lysine with 2-oxoglutarate to form L-saccharopine, using NADPH, as the first
committed step of the saccharopine pathway of L-lysine degradation in the
mitochondrial matrix.
molecular_function:
id: GO:0047130
label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
directly_involved_in:
- id: GO:0019477
label: L-lysine catabolic process
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:463877
supporting_text: >-
In all instances there was a deficiency in lysine-ketoglutarate reductase,
saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- reference_id: PMID:10775527
supporting_text: >-
The first two steps in the mammalian lysine-degradation pathway are catalyzed by
lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
- description: >-
Saccharopine dehydrogenase (SDH) activity: the C-terminal domain oxidizes
L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic semialdehyde)
and L-glutamate, reducing NAD+, as the second step of the saccharopine pathway of
L-lysine degradation in the mitochondrial matrix.
molecular_function:
id: GO:0047131
label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
directly_involved_in:
- id: GO:0019477
label: L-lysine catabolic process
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:463877
supporting_text: >-
In all instances there was a deficiency in lysine-ketoglutarate reductase,
saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- reference_id: PMID:10775527
supporting_text: >-
The first two steps in the mammalian lysine-degradation pathway are catalyzed by
lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
references:
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
ISS pipeline reference. The transferred nuclear/transcriptional and lysine-forming
annotations derive from the Drosophila ortholog (UniProtKB:Q9VLX0) and are not
supported for human AASS.
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
PAN-GO/IBA pipeline; correctly recovers the core saccharopine-pathway function and
lysine catabolic process.
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: SubCell keyword mapping to mitochondrion; consistent with experimental data.
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Ensembl Compara transfer from mouse Q99K67; correctly places AASS in the mitochondrial matrix.
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
ARBA/RHEA/EC mapping recovering both catalytic activities (EC 1.5.1.8 and 1.5.1.9);
consistent with UniProt and experimental annotations.
- id: PMID:10567240
title: 'Lysine degradation through the saccharopine pathway in mammals: involvement
of both bifunctional and monofunctional lysine-degrading enzymes in mouse.'
findings:
- statement: >-
Characterizes a mammalian (mouse) bifunctional lysine-oxoglutarate
reductase/saccharopine dehydrogenase and infers mitochondrial localization; also
reports starvation induction.
reference_section_type: ABSTRACT
supporting_text: >-
the bifunctional enzyme is likely to be a mitochondrial protein.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Establishes the mammalian bifunctional LKR/SDH and its mitochondrial
localization and starvation induction (ortholog of human AASS).
- id: PMID:10775527
title: Identification of the alpha-aminoadipic semialdehyde synthase gene, which
is defective in familial hyperlysinemia.
findings:
- statement: >-
Identifies human AASS as a bifunctional enzyme (N-terminal LKR ~ yeast LYS1,
C-terminal SDH ~ yeast LYS9) catalyzing the first two steps of lysine degradation;
inactivating mutations cause hyperlysinemia.
reference_section_type: ABSTRACT
supporting_text: >-
we propose that AASS catalyzes the first two steps of the major lysine-degradation
pathway in human cells and that inactivating mutations in the AASS gene are a cause
of hyperlysinemia.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Defining reference for the human gene, its bifunctional domain
organization, and the disease link (HYPLYS1).
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings:
- statement: AASS is a member of the high-confidence human mitochondrial proteome (MitoCoP).
reference_section_type: ABSTRACT
supporting_text: >-
mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
PubMed-verified proteomics dataset; supports mitochondrial localization at proteome
scale (HTP evidence).
- id: PMID:463877
title: 'Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on
terminology.'
findings:
- statement: >-
Enzyme studies in hyperlysinemia patients show combined deficiency of
lysine-ketoglutarate reductase and saccharopine dehydrogenase; the activities
co-purify from human liver and localize to the same protein.
reference_section_type: ABSTRACT
supporting_text: >-
In all instances there was a deficiency in lysine-ketoglutarate reductase,
saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Experimental basis for both AASS enzyme activities and for the
type I / saccharopinuria distinction.
- id: Reactome:R-HSA-70938
title: lysine + alpha-ketoglutarate +NADPH + H+ => saccharopine + NADP+ + H2O
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Reactome reaction for the LKR step; localized to the mitochondrial matrix.
- id: Reactome:R-HSA-70940
title: saccharopine + NAD+ + H2O => alpha-aminoadipic semialdehyde + glutamate +
NADH + H+
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Reactome reaction for the SDH step; localized to the mitochondrial matrix.
proposed_new_terms: []
suggested_questions:
- question: >-
Does human AASS have any validated moonlighting function outside the mitochondrion (e.g.
a nuclear/transcriptional role analogous to that reported for the Drosophila ortholog),
or is such a role restricted to insects?
suggested_experiments:
- description: >-
Test whether endogenous AASS is detectable in the nucleus of human cells and whether it
associates with chromatin or represses transcription, to determine if the Drosophila-derived
transcriptional moonlighting annotations are conserved in humans.